Skip to main content
Clinical Trials/IRCT20220110053681N1
IRCT20220110053681N1Not yet recruitingPhase 3

Evaluation of the Effects of Sertraline on the Prognosis of Patients with Covid - 19 Admitted to Hospital

Sabzevar University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Patients 18-65 years old with Covid-19 need to be hospitalized
  • Patient consent to participate in the study

Exclusion Criteria

  • Effective underlying diseases as a result of the study, whether previous cardiovascular or pulmonary diseases or other diseases and special conditions such as diabetes, weakened immune system and pregnancy
  • History of psychiatric illness or previous use of SSRIs including Sertraline

Investigators

Sponsor
Sabzevar University of Medical Sciences

Similar Trials